Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Lilach Bonstein"'
Publikováno v:
Hematology Reports, Vol 3, Iss 3, Pp e29-e29 (2011)
The outcome and quality of life of chronic myeloid leukemia (CML) patients has remarkably changed with the treatment of tyrosine kinase inhibitors (TKIs). Currently, hematopoietic stem cell transplantation (HSCT) is considered mainly as a third line
Externí odkaz:
https://doaj.org/article/0e094d3b4fd142f2b762a92f1a3571ca
Autor:
Vered S. Zemer, Katherin Mousa, Tina Herscovici, Orna Steinberg-Shemer, Lilach Bonstein, Joanne Yacobovich
Publikováno v:
Journal of Pediatric Hematology/Oncology.
Autor:
Assaf Barg, Lilach Bonstein
Publikováno v:
Seminars in thrombosis and hemostasis.
Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is a common cause of severe thrombocytopenia in newborns. Intracranial bleeding may lead to severe neurological sequelae and mortality. Current management of pregnancies at risk is suboptimal. Pr
Publikováno v:
The Thoracic and Cardiovascular Surgeon. 69:719-722
Cardiopulmonary bypass (CPB) is associated with platelet dysfunction (PD), an important cause of postoperative bleeding. The etiology of PD is not completely understood. We mapped the platelets' function during CPB to determine the etiology of PD. Pl
Autor:
Chen Ben David, Or Inbal, Roee Iluz, Amir Weissman, Nizar Khatib, Yuval Ginsberg, Ron Beloosesky, Zeev Weiner, Ido Solt, Dana Vitner, Lilach Bonstein, Yaniv Zipori
Publikováno v:
SSRN Electronic Journal.
Autor:
Boaz Tadmor, Pia Raanani, Galia Spectre, Lilach Bonstein, Nardeen Atweh, Anna Gurevich-Shapiro, M. Shapiro, Tsipora Gruenewal
Publikováno v:
Transfusion. 58:493-497
Background Intravenous immunoglobulin (IVIG) has known efficacy in various hematologic conditions, including immune thrombocytopenic purpura. Study design and methods We present the clinical course of a patient with splenic marginal zone lymphoma, wh
Publikováno v:
Anti-Cancer Drugs. 28:811-814
Checkpoint inhibitors effectively enhance the natural immune response against cancer, but they are also known to induce a unique spectrum of immune-related adverse events. Here, we report the first case of isolated neutropenia subsequent to nivolumab
Publikováno v:
Harefuah. 158(3)
To determine the prevalence and incidence of HPA antigens and antibodies in the Israeli population and to evaluate the degree of awareness to F/NAIT in Israel.In fetal/neonatal alloimmune thrombocytopenia (F/NAIT) the fetus suffers from thrombocytope
Autor:
Hanna Mandel, Dror Mevorach, Vered Yahalom, Adi Mory, David Azoulay, Omer Weissbrod, Hagit N. Baris, Yaniv Zohar, Lilach Finkel, Adi Tabib, Ron Shaoul, Sarit Peleg, Alina Kurolap, Lilach Bonstein, Orly Eshach-Adiv, Daniella Magen, Elizabeth E. Half, Tamar Paperna, Danit Oz-Levi, Judith Chezar, Tova Hershkovitz, Dan Geiger
Publikováno v:
New England Journal of Medicine. 377:87-89
CD55 (complement decay-accelerating factor) inhibits the alternative and classical arms of the complement pathway. Three patients with protein-losing enteropathy and a genetic variant predicted to result in loss of function of CD55 had a response to
Autor:
Anna, Gurevich-Shapiro, Lilach, Bonstein, Galia, Spectre, Nardeen, Atweh, Tsipora, Gruenewal, Michael, Shapiro, Boaz, Tadmor, Pia, Raanani
Publikováno v:
Transfusion. 58(2)
Intravenous immunoglobulin (IVIG) has known efficacy in various hematologic conditions, including immune thrombocytopenic purpura.We present the clinical course of a patient with splenic marginal zone lymphoma, who developed acute thrombocytopenia on